KR20160030093A - 구강 내 붕괴정 - Google Patents

구강 내 붕괴정 Download PDF

Info

Publication number
KR20160030093A
KR20160030093A KR1020157034575A KR20157034575A KR20160030093A KR 20160030093 A KR20160030093 A KR 20160030093A KR 1020157034575 A KR1020157034575 A KR 1020157034575A KR 20157034575 A KR20157034575 A KR 20157034575A KR 20160030093 A KR20160030093 A KR 20160030093A
Authority
KR
South Korea
Prior art keywords
mass
content
disintegrating tablet
less
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020157034575A
Other languages
English (en)
Korean (ko)
Inventor
마사히로 곤도
나오야 오치아이
유키 사카쿠라
Original Assignee
가부시키가이샤산와카가쿠켄큐쇼
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 가부시키가이샤산와카가쿠켄큐쇼 filed Critical 가부시키가이샤산와카가쿠켄큐쇼
Publication of KR20160030093A publication Critical patent/KR20160030093A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020157034575A 2013-07-19 2014-07-17 구강 내 붕괴정 Withdrawn KR20160030093A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013150410 2013-07-19
JPJP-P-2013-150410 2013-07-19
PCT/JP2014/069024 WO2015008825A1 (ja) 2013-07-19 2014-07-17 口腔内崩壊錠

Publications (1)

Publication Number Publication Date
KR20160030093A true KR20160030093A (ko) 2016-03-16

Family

ID=52346267

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157034575A Withdrawn KR20160030093A (ko) 2013-07-19 2014-07-17 구강 내 붕괴정

Country Status (6)

Country Link
US (1) US20160136091A1 (enExample)
EP (1) EP3023109A4 (enExample)
JP (2) JP5713421B1 (enExample)
KR (1) KR20160030093A (enExample)
CN (1) CN105377303B (enExample)
WO (1) WO2015008825A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6506752B2 (ja) * 2013-07-19 2019-04-24 バイエル ファーマ アクチエンゲゼルシャフト Ａｐｉミグリトールのための超速崩壊錠剤処方
CN105943525A (zh) * 2016-06-02 2016-09-21 中国药科大学 一种保肝药物组合物
CN114432424B (zh) * 2021-12-27 2023-06-27 南通联亚药业股份有限公司 一种稳定的铝塑包装去氨加压素片剂
CN115813870B (zh) * 2022-12-21 2024-05-10 江苏吴中医药集团有限公司 卡络磺钠片及其制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292729A (en) * 1992-08-14 1994-03-08 Albion International, Inc. II-bond aromatic vitamin chelates
JP4802436B2 (ja) 2000-04-12 2011-10-26 Ｍｓｄ株式会社 口腔内崩壊型組成物及び口腔内崩壊型製剤
BR0112295B1 (pt) 2000-06-20 2011-06-14 mÉtodo para a fabricaÇço de um artigo moldado tendo um nécleo, dispositivo para a fabricaÇço de um artigo moldado tendo um nécleo, artigo moldado e agregado de artigos moldados.
JP4162405B2 (ja) 2000-12-28 2008-10-08 エーザイ・アール・アンド・ディー・マネジメント株式会社 鋳型錠
EP1430888A1 (en) 2001-09-28 2004-06-23 Sanwa Kagaku Kenkyusho Co., Ltd. Press-coated molded article undergoing quick disintegration
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
JP4551627B2 (ja) 2003-02-28 2010-09-29 東和薬品株式会社 口腔内崩壊錠剤の製造方法
JP5584509B2 (ja) 2003-02-28 2014-09-03 東和薬品株式会社 口腔内崩壊錠剤
JP5062871B2 (ja) 2003-05-13 2012-10-31 東和薬品株式会社 苦味を低減した口腔内崩壊錠剤
JP5062872B2 (ja) 2003-08-13 2012-10-31 東和薬品株式会社 不快な味を低減した口腔内崩壊錠剤
JP3841804B2 (ja) * 2003-10-15 2006-11-08 富士化学工業株式会社 口腔内速崩壊性錠剤用の組成物
CN1615862A (zh) * 2003-11-10 2005-05-18 浙江医药股份有限公司新昌制药厂 一种治疗ⅱ型糖尿病的米格列醇口腔崩解片及其制备方法
JP2005187349A (ja) * 2003-12-24 2005-07-14 Lion Corp 口腔内崩壊錠
WO2005123040A1 (ja) 2004-06-22 2005-12-29 Shionogi & Co., Ltd. 口腔内速崩壊錠
JP4446177B2 (ja) 2005-01-21 2010-04-07 東和薬品株式会社 耐湿性口腔内崩壊錠の製造方法
WO2006087629A2 (en) * 2005-02-21 2006-08-24 Aurobindo Pharma Limited Rapidly disintegrating composition of olanzapine
BRPI0709909A2 (pt) 2006-03-31 2011-07-26 Rubicon Res Private Ltd tabletes de desintegraÇço oral
WO2009043844A2 (en) * 2007-10-01 2009-04-09 Laboratorios Lesvi, S.L. Orodispersible tablets
WO2009066773A1 (ja) 2007-11-21 2009-05-28 Dainippon Sumitomo Pharma Co., Ltd. 口腔内崩壊錠
MX2010005175A (es) 2007-12-08 2010-08-02 Bayer Schering Pharma Ag Comprimido dispersable oral.
EP2262487A2 (en) 2008-02-29 2010-12-22 Otsuka Pharmaceutical Co., Ltd. An orally disintegrating tablet of cilostazol
KR20110117133A (ko) * 2009-01-29 2011-10-26 다이닛본 스미토모 세이야꾸 가부시끼가이샤 내핵을 갖는 구강 내 붕괴 정
WO2010122583A2 (en) * 2009-04-24 2010-10-28 Rubicon Research Private Limited Oral pharmaceutical compositions of acid labile substances
JP5575119B2 (ja) 2009-05-20 2014-08-20 大日本住友製薬株式会社 口腔内崩壊錠
WO2010134540A1 (ja) 2009-05-20 2010-11-25 大日本住友製薬株式会社 有核型の口腔内崩壊錠
EP2465540B1 (en) * 2009-08-11 2016-10-05 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and orally rapidly disintegrating tablet
JP5674666B2 (ja) * 2009-08-11 2015-02-25 富士化学工業株式会社 崩壊性粒子組成物及び口腔内速崩壊錠
TR201901905T4 (tr) 2009-12-11 2019-03-21 Sumitomo Dainippon Pharma Co Ltd Kuru kaplanmış ağızda dağılan tablet.
JPWO2012001977A1 (ja) * 2010-06-29 2013-08-22 富士化学工業株式会社 崩壊性組成物及び易崩壊性圧縮成型物
JP2012197245A (ja) * 2011-03-22 2012-10-18 Kowa Co 新規な口腔内崩壊錠

Also Published As

Publication number Publication date
JP5713421B1 (ja) 2015-05-07
HK1220139A1 (zh) 2017-04-28
WO2015008825A1 (ja) 2015-01-22
EP3023109A4 (en) 2017-01-04
CN105377303B (zh) 2019-04-05
EP3023109A1 (en) 2016-05-25
JPWO2015008825A1 (ja) 2017-03-02
JP2015129175A (ja) 2015-07-16
US20160136091A1 (en) 2016-05-19
CN105377303A (zh) 2016-03-02

Similar Documents

Publication Publication Date Title
ES2820536T3 (es) Composición farmacéutica novedosa
US20120171296A1 (en) Rapidly disintegrating solid preparation
ES2663135T3 (es) Formulaciones orales de deferasirox
DK2510950T3 (en) DRY-COATED ORALT-DISINTEGRATING TABLE
JP2009114113A (ja) 口腔内崩壊錠及びその製造方法
JP7036856B2 (ja) 口腔内崩壊錠
JPWO2010106936A1 (ja) 口腔内崩壊錠
KR101828630B1 (ko) 구강 내 붕괴 정제
US7993673B2 (en) Swallow tablet comprising paracetamol
KR20160030093A (ko) 구강 내 붕괴정
JP7198575B2 (ja) メマンチン塩酸塩含有口腔内崩壊錠
JP5686452B2 (ja) イルベサルタンを含有する錠剤
JP6723229B2 (ja) アルペリシブを含む医薬組成物
AU2011379627B2 (en) Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof
ES2985625T3 (es) Formas de dosificación sólidas de vigabatrina
JP7148319B2 (ja) プラスグレルを含む口腔内崩壊錠
JP5226732B2 (ja) 催眠用圧縮成型製剤
US20200323780A1 (en) Bilayer combination tablet for oral administration containing tramadol and celecoxib
SAJJA FORMULATION AND IN-VITRO EVALUATION OF ORALLY ADMINISTERED GASTRO-RETENTIVE FLOATING TABLETS OF IMATINIB
HK1220139B (zh) 口腔崩解片

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20151204

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20190520

Comment text: Request for Examination of Application

PC1202 Submission of document of withdrawal before decision of registration

Comment text: [Withdrawal of Procedure relating to Patent, etc.] Withdrawal (Abandonment)

Patent event code: PC12021R01D

Patent event date: 20200410